These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1544607)

  • 21. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the effect of tridiphane on the pharmacokinetics of [14C]-atrazine following oral administration to male Fischer 344 rats.
    Timchalk C; Dryzga MD; Langvardt PW; Kastl PE; Osborne DW
    Toxicology; 1990 Mar; 61(1):27-40. PubMed ID: 2315949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
    Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption and mass balance of piperonyl butoxide following an 8-h dermal exposure in human volunteers.
    Selim S; Preiss FJ; Gabriel KL; Jonkman JH; Osimitz TG
    Toxicol Lett; 1999 Jun; 107(1-3):207-17. PubMed ID: 10414798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The absorption, tissue distribution and excretion of di-n-octyltin dichloride in rats.
    Penninks AH; Hilgers L; Seinen W
    Toxicology; 1987 Apr; 44(1):107-20. PubMed ID: 3564046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
    Keener SA; Wrbitzky R; Bader M
    Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA; Clark AJ; McClymont EL; Staley JL
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air.
    Carnerup MA; Spanne M; Jönsson BA
    Toxicol Lett; 2006 Apr; 162(2-3):139-45. PubMed ID: 16321482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous absorption and dermal dose-cholinesterase response studies with parathion and carbaryl in the rat.
    Knaak JB; Yee K; Ackerman CR; Zweig G; Fry DM; Wilson BW
    Toxicol Appl Pharmacol; 1984 Nov; 76(2):252-63. PubMed ID: 6437015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration].
    Kellner HM; Arnold C; Christ OE; Eckert HG; Herok J; Hornke I; Rupp W
    Arzneimittelforschung; 1981; 31(8A):1337-53. PubMed ID: 7197541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous penetration and metabolism of 2-butoxyethanol.
    Lockley DJ; Howes D; Williams FM
    Arch Toxicol; 2004 Nov; 78(11):617-28. PubMed ID: 15455191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous absorption, disposition, and excretion of 4,4'-methylenebis(2-chloroaniline) in dogs.
    Manis MO; Williams DE; McCormack KM; Schock RJ; Lepper LF; Ng YC; Braselton WE
    Environ Res; 1984 Feb; 33(1):234-45. PubMed ID: 6692810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diethanolamine absorption, metabolism and disposition in rat and mouse following oral, intravenous and dermal administration.
    Mathews JM; Garner CE; Black SL; Matthews HB
    Xenobiotica; 1997 Jul; 27(7):733-46. PubMed ID: 9253149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermal absorption of chemicals: effect of application of chemicals as a solid, aqueous paste, suspension, or in volatile vehicle.
    Hughes MF; Shrivastava SP; Sumler MR; Edwards BC; Goodwin JH; Shah PV; Fisher HL; Hall LL
    J Toxicol Environ Health; 1992 Sep; 37(1):57-71. PubMed ID: 1522614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
    Timchalk C; Smith FA; Bartels MJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermal absorption of niclosamide in rats and minipigs.
    Brennan P; Johnson D; Rider S; Cone N; Goldman M; Buckpitt A; Chung H
    Biopharm Drug Dispos; 1991 Oct; 12(7):547-56. PubMed ID: 1932616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats.
    Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K
    Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.